A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease
Status:
Completed
Trial end date:
2016-11-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ticagrelor is effective in reducing the
number of days of pain, intensity of pain, and reducing the use of analgesics due to sickle
cell disease